Skip to content

HBIO - HARVARD BIOSCIENCE INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchH

Harvard Bioscience Inc

HBIO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

H

HBIOHarvard Bioscience Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $9.40
52-wk low: $3.76
Prev close: $6.82
Mkt cap: $32.2M
Fwd P/E: 15.1x
Beta: 1.49

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$2.1M

TS
Two Sigma
Q2 2026 13F
$704K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 4.8% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -11.9%
Forward P/E: 15.06
Market cap: $32M

Valuation

P/S0.37
P/B4.28

Quality

Operating margin-2.9%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: HBIO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Market cap: $32.23M
Beta: 1.49

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.4x

P/B

4.3x

Profit margin

-11.9%

Op margin

-2.9%

ROE

-89.9%

$611K

position

MI

Millennium

Israel Englander · Q2 2026 13F

$201K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for HBIO

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.22-4.8%

-$0.21 expected

Next report

What the street expects next

ROE

-89.9%

ROA1.6%

Growth

Beta1.49